Subscribe to RSS - Peter Farrell

Peter Farrell

ResMed officials sell shares


SAN DIEGO – ResMed Director Peter Farrell on Aug. 1 sold 25,000 shares of stock at an average price of $49.04 for a total transaction of about $1.23 million. Farrell now owns 279,990 shares valued at about $13.73 million. Also on Aug.

Farrell unloads ResMed stock


SAN DIEGO – Peter Farrell, the former CEO of ResMed and a current director, sold 25,000 shares of company stock on the open market in a transaction dated May 1. The stock was sold at $49.80 for a total value of $1.245 million.

ResMed founder named to CONNECT Hall of Fame


SAN DIEGO – ResMed Founder Peter Farrell has been inducted into the CONNECT Entrepreneur Hall of Fame for his work in sleep and respiratory medicine, the company announced Feb. 19.

ResMed director sells $1.2m in company stock


SAN DIEGO – Peter Farrell, ResMed director, sold 25,000 shares of stock on Sept. 5.

ResMed promotes Michael Farrell to CEO


POWAY, Calif. – Michael “Mick” Farrell, president of ResMed’s Americas division since 2011, will replace his father, Peter Farrell, as CEO and be appointed to the company’s board effective March 1, according to a press release.

ResMed CEO sells 400,000 shares


SAN DIEGO – ResMed CEO and Executive Chairman Peter Farrell sold 400,000 shares at an average price of $46.98 on Jan. 30, according to an article from

ResMed reports double-digit increases

'We’ve been pioneering a market dynamic that is finally getting traction'

SAN DIEGO – With home sleep testing (HST) gaining ground and new products in the works, 2013 should be a good year for ResMed, officials reported last week.

ResMed to select new CEO in early 2013


SAN DIEGO – ResMed is on track to choose an internal candidate as its next CEO in early 2013, The Australian has reported. The two candidates vying for the position: Michael Farrell, president of Americas; and Robert Douglas, COO.

ResMed mulls move


SAN DIEGO – ResMed is evaluating whether it should move its headquarters out of California, according to news reports.

ResMed announces record quarter


SAN DIEGO – ResMed this week reported revenue of $339.7 million for the quarter ended Sept. 30, 2012, an 8% increase over the same quarter last year. Net income was $71.3 million, a 41% increase; and earnings per share were $0.49, a 48% increase.